BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 37450557)

  • 1. Epigenetic Causes of Overgrowth Syndromes.
    Lui JC; Baron J
    J Clin Endocrinol Metab; 2024 Jan; 109(2):312-320. PubMed ID: 37450557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-occurrence of a maternally inherited
    Polonis K; Blackburn PR; Urrutia RA; Lomberk GA; Kruisselbrink T; Cousin MA; Boczek NJ; Hoppman NL; Babovic-Vuksanovic D; Klee EW; Pichurin PN
    Cold Spring Harb Mol Case Stud; 2018 Aug; 4(4):. PubMed ID: 29802153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal abnormalities in mice with Dnmt3a missense mutations.
    Bell-Hensley A; Beard DC; Feeney K; Zheng H; Jiang Y; Zhang X; Liu J; Gabel H; McAlinden A
    Bone; 2024 Jun; 183():117085. PubMed ID: 38522809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further delineation of neuropsychiatric findings in Tatton-Brown-Rahman syndrome due to disease-causing variants in DNMT3A: seven new patients.
    Tenorio J; Alarcón P; Arias P; Dapía I; García-Miñaur S; Palomares Bralo M; Campistol J; Climent S; Valenzuela I; Ramos S; Monseny AM; Grondona FL; Botet J; Serrano M; Solís M; Santos-Simarro F; Álvarez S; Teixidó-Tura G; Fernández Jaén A; Gordo G; Bardón Rivera MB; Nevado J; Hernández A; Cigudosa JC; Ruiz-Pérez VL; Tizzano EF; ; Lapunzina P
    Eur J Hum Genet; 2020 Apr; 28(4):469-479. PubMed ID: 31685998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma.
    Berdasco M; Ropero S; Setien F; Fraga MF; Lapunzina P; Losson R; Alaminos M; Cheung NK; Rahman N; Esteller M
    Proc Natl Acad Sci U S A; 2009 Dec; 106(51):21830-5. PubMed ID: 20018718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in Epigenetic Regulation Genes Are a Major Cause of Overgrowth with Intellectual Disability.
    Tatton-Brown K; Loveday C; Yost S; Clarke M; Ramsay E; Zachariou A; Elliott A; Wylie H; Ardissone A; Rittinger O; Stewart F; Temple IK; Cole T; ; Mahamdallie S; Seal S; Ruark E; Rahman N
    Am J Hum Genet; 2017 May; 100(5):725-736. PubMed ID: 28475857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case Report: Bilateral Epiphysiodesis Due to Extreme Tall Stature in a Girl With a
    Lennartsson O; Lodefalk M; Wehtje H; Stattin EL; Sävendahl L; Nilsson O
    Front Endocrinol (Lausanne); 2021; 12():752756. PubMed ID: 34721301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in SETD2 cause a novel overgrowth condition.
    Luscan A; Laurendeau I; Malan V; Francannet C; Odent S; Giuliano F; Lacombe D; Touraine R; Vidaud M; Pasmant E; Cormier-Daire V
    J Med Genet; 2014 Aug; 51(8):512-7. PubMed ID: 24852293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth disrupting mutations in epigenetic regulatory molecules are associated with abnormalities of epigenetic aging.
    Jeffries AR; Maroofian R; Salter CG; Chioza BA; Cross HE; Patton MA; Dempster E; Temple IK; Mackay DJG; Rezwan FI; Aksglaede L; Baralle D; Dabir T; Hunter MF; Kamath A; Kumar A; Newbury-Ecob R; Selicorni A; Springer A; Van Maldergem L; Varghese V; Yachelevich N; Tatton-Brown K; Mill J; Crosby AH; Baple EL
    Genome Res; 2019 Jul; 29(7):1057-1066. PubMed ID: 31160375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrum of NSD1 mutations in Sotos and Weaver syndromes.
    Rio M; Clech L; Amiel J; Faivre L; Lyonnet S; Le Merrer M; Odent S; Lacombe D; Edery P; Brauner R; Raoul O; Gosset P; Prieur M; Vekemans M; Munnich A; Colleaux L; Cormier-Daire V
    J Med Genet; 2003 Jun; 40(6):436-40. PubMed ID: 12807965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tatton-Brown-Rahman Syndrome: Case report and DNMT3A variant not previously reported associated to the syndrome].
    Martin M F; Díaz S C; Mira O M
    Andes Pediatr; 2022 Aug; 93(4):561-567. PubMed ID: 37906855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tatton-Brown-Rahman syndrome due to 2p23 microdeletion.
    Okamoto N; Toribe Y; Shimojima K; Yamamoto T
    Am J Med Genet A; 2016 May; 170A(5):1339-42. PubMed ID: 26866722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss-of-function variant in SPIN4 causes an X-linked overgrowth syndrome.
    Lui JC; Wagner J; Zhou E; Dong L; Barnes KM; Jee YH; Baron J
    JCI Insight; 2023 May; 8(9):. PubMed ID: 36927955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ezh2 Mutations Found in the Weaver Overgrowth Syndrome Cause a Partial Loss of H3K27 Histone Methyltransferase Activity.
    Lui JC; Barnes KM; Dong L; Yue S; Graber E; Rapaport R; Dauber A; Nilsson O; Baron J
    J Clin Endocrinol Metab; 2018 Apr; 103(4):1470-1478. PubMed ID: 29244146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An adult patient with Tatton-Brown-Rahman syndrome caused by a novel DNMT3A variant and axonal polyneuropathy.
    AlSabah AA; Alsalmi M; Massie R; Bilodeau MC; Campeau PM; McGraw S; D'Agostino MD
    Am J Med Genet A; 2024 Apr; 194(4):e63484. PubMed ID: 38041495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tatton-Brown-Rahman syndrome: Novel pathogenic variants and new neuroimaging findings.
    Jiménez de la Peña M; Rincón-Pérez I; López-Martín S; Albert J; Martín Fernández-Mayoralas D; Fernández-Perrone AL; Jiménez de Domingo A; Tirado P; Calleja-Pérez B; Porta J; Álvarez S; Fernández-Jaén A
    Am J Med Genet A; 2024 Feb; 194(2):211-217. PubMed ID: 37795572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NSD1 mutations are the major cause of Sotos syndrome and occur in some cases of Weaver syndrome but are rare in other overgrowth phenotypes.
    Douglas J; Hanks S; Temple IK; Davies S; Murray A; Upadhyaya M; Tomkins S; Hughes HE; Cole TR; Rahman N
    Am J Hum Genet; 2003 Jan; 72(1):132-43. PubMed ID: 12464997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aortic root dilatation and dilated cardiomyopathy in an adult with Tatton-Brown-Rahman syndrome.
    Cecchi AC; Haidar A; Marin I; Kwartler CS; Prakash SK; Milewicz DM
    Am J Med Genet A; 2022 Feb; 188(2):628-634. PubMed ID: 34644003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weaver syndrome and EZH2 mutations: Clarifying the clinical phenotype.
    Tatton-Brown K; Murray A; Hanks S; Douglas J; Armstrong R; Banka S; Bird LM; Clericuzio CL; Cormier-Daire V; Cushing T; Flinter F; Jacquemont ML; Joss S; Kinning E; Lynch SA; Magee A; McConnell V; Medeira A; Ozono K; Patton M; Rankin J; Shears D; Simon M; Splitt M; Strenger V; Stuurman K; Taylor C; Titheradge H; Van Maldergem L; Temple IK; Cole T; Seal S; ; Rahman N
    Am J Med Genet A; 2013 Dec; 161A(12):2972-80. PubMed ID: 24214728
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Tlemsani C; Luscan A; Leulliot N; Bieth E; Afenjar A; Baujat G; Doco-Fenzy M; Goldenberg A; Lacombe D; Lambert L; Odent S; Pasche J; Sigaudy S; Buffet A; Violle-Poirsier C; Briand-Suleau A; Laurendeau I; Chin M; Saugier-Veber P; Vidaud D; Cormier-Daire V; Vidaud M; Pasmant E; Burglen L
    J Med Genet; 2016 Nov; 53(11):743-751. PubMed ID: 27317772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.